Skip to main content
SpringerLink
Log in

Reproductive releasing hormones — the future

  • Chapter
Fertility and Sterility

  • 128 Accesses

Abstract

In the treatment of reproductive disorders, gonadotrophin preparations and steroid hormones have traditionally had an important role. More recently, the therapeutic potential of synthetic hypothalamic hormone analogues has been established in reproductive and non-reproductive disorders. Due to the complexity of hypothalamic-pituitary-gonadal interactions, the transition from physiology and pharmacology to clinical medicine has sometimes been difficult, but a review of the current results indicates that we can look forward to the future with confidence. The development of potent peptide hormone analogues, new biomedical devices for pulsatile administration and sustained delivery, and sophisticated experimental methods for the evaluation of hypothalamic-pituitary-gonadal function have all contributed to a rapid application of the experimental concepts to clinical reality.

This is a preview of subscription content, log in via an institution to check access.

Access this chapter

Log in via an institution
Chapter
USD 29.95
Price excludes VAT (USA)
  • Available as PDF
  • Read on any device
  • Instant download
  • Own it forever
eBook
USD 84.99
Price excludes VAT (USA)
  • Available as EPUB and PDF
  • Read on any device
  • Instant download
  • Own it forever
Softcover Book
USD 109.99
Price excludes VAT (USA)
  • Compact, lightweight edition
  • Dispatched in 3 to 5 business days
  • Free shipping worldwide - see info

Tax calculation will be finalised at checkout

Purchases are for personal use only

Institutional subscriptions

Preview

Unable to display preview. Download preview PDF.

Unable to display preview. Download preview PDF.

References

  1. Schally, A. V., Arimura, A. and Coy, D. H. (1981). Recent approaches to fertility control based on derivatives of LH-RH. Vitam. Horm, 38, 257

    Article  Google Scholar 

  2. Yen, S. S. C. (1983). Clinical applications of gonadotropin-releasing hormone and gonadotropin-releasing hormone analogs. Fertil. Steril, 39, 257

    PubMed  CAS  Google Scholar 

  3. Swerdloff, R. S. and Heber, D. (1983). Superactive gonadotropin-releasing hormone agonists. Ann. Rev. Med, 34, 491

    Article  PubMed  CAS  Google Scholar 

  4. Sandow, J. (1983). Clinical applications of LHRH and its analogues. Clin. Endocrinol, 18, 571

    Article  CAS  Google Scholar 

  5. Pineda, J. L., Lee, B. C., piliotis, B.E., et al (1983). Effect of GnRH antagonist (Acdelta3Pro1,pFDPhe2,DTrp3.6)GnRH, on pulsatile gonadotropin secretion in the castrate male primate. J. Clin. Endocrinol. Metab, 56, 420

    Article  PubMed  CAS  Google Scholar 

  6. Redding, T. W., Coy, D. H. and Schally, A. V. (1982). Prostate carcinoma tumor size in rats decreases after administration of antagonists of luteinizing hormone-releasing hormone. Proc. Natl. Acad. Sci. USA, 79, 1273

    Article  PubMed  CAS  Google Scholar 

  7. Rivier, C., Rivier, J. and Vale, W. (1979). Effect of the LRF-antagonist (D-pGlu’,DPhe2,D-Trp3’6)-LRF on pregnancy in the rat. Contraception, 19, 185

    Article  PubMed  CAS  Google Scholar 

  8. Rivier, C., Rivier, J. and Vale, W. (1981). Antireproductive effects of a potent GnRH antagonist in the female rat. Endocrinology, 108, 1425

    Article  PubMed  CAS  Google Scholar 

  9. Knobil, E. (1980). The neuroendocrine control of the menstrual cycle. Recent Prog. Horm. Res, 36, 53

    PubMed  CAS  Google Scholar 

  10. Fraser, H. M., Sharpe, R. M., Lincoln, G. A. and Harmer, A. J. (1982). LHRH antibodies: Their use in the study of hypothalamic LHRH and testicular LHRHlike material, and possible contraceptive applications. In Jeffcoate, S. L. and Sandler, M. (eds.). Progress Towards a Male Contraceptive, pp. 41–78. ( London: John Wiley and Sons )

    Google Scholar 

  11. Badger, T. M., Loughlin, J. S. and Naddaff, P. G. (1983). The luteinizing hormone-releasing hormone (LHRH)-desensitized rat pituitary: luteinizing hormone responsiveness to LHRH in vitro. Endocrinology, 112, 793

    Article  CAS  Google Scholar 

  12. Yeo, T., Grossman, A., Belchetz, P. and Besser, G. M. (1982). Response of luteinizing hormone from columns of dispersed rat pituitary cells to a highly potent analogue of luteinizing hormone releasing hormone. J. Endocrinol, 91, 33

    Article  Google Scholar 

  13. Clayton, R. N. and Catt, K. J. (1981). Gonadotropin-releasing hormone receptors: characterization, physiological regulation, and relationship to reproductive function. Endocrinol. Rev, 2, 186

    Article  CAS  Google Scholar 

  14. Sandow, J. (1982). Gonadotropic and antigonadotropic actions of LH-RH analogues. In Müller, E. E. and McLeod, R. M. (eds.). Neuroendocrine Perspectives. Vol. 1, pp. 339–95. ( Amsterdam: Elsevier Biomedical Press )

    Google Scholar 

  15. Bint Akhtar, F., Marshall, G. R., Wickings, J. and Nieschlag, E. (1983). Reversible induction of azoospermia in rhesus monkeys by constant infusion of a gonadotropin-releasing hormone agonist using osmotic minipumps. J. Clin. Endocrinol. Metab, 56, 534

    Article  Google Scholar 

  16. Vickery, B. H. (1981). Physiology and antifertility effects of LHRH and agonistic analogs in male animals. In Zatuchni, G. I., Shelton, J. D. and Sciarra, J. J. (eds.). LHRH Peptides as Female and Male Contraceptives, pp. 275–90. ( Philadelphia: Harper & Row )

    Google Scholar 

  17. Sandow, J. (1982). Inhibition of pituitary and testicular function by LHRH and analogues. In Jeffcoate, S. L. and Sandler, M. (eds.). Progress Towards a Male Contraceptive, pp. 19–39. ( London: John Wiley and Sons )

    Google Scholar 

  18. Fraser, H. M. (1983). Effect of treatment for 1 year with a luteinizing hormone-releasing hormone agonist on ovarian, thyroidal, and adrenal function and menstruation in the stumptailed monkey (Macaca arctoides). Endocrinology, 112, 245

    Article  PubMed  CAS  Google Scholar 

  19. Sandow, J., Jerabek-Sandow, G., Krauss, B. and Stoll, W. (1982). Metabolic and dispositional studies with LHRH analogs. In Zatuchni, G. I., Shelton, J. D. and Sciarra, J. J. (eds.). LHRH Peptides as Female and Male Contraceptives, pp. 321–36. ( Philadelphia: Harper & Row )

    Google Scholar 

  20. Schmidt-Gollwitzer, M., Hardt, W., Schmidt-Gollwitzer, K. and von der Ohe, M. (1982). The contraceptive use of Buserelin, a potent LH-RH agonist: clinical and hormonal findings. In Zatuchni, G. I., Shelton, J. D. and Sciarra, J. J. (eds.). LHRH Peptides as Female and Male Contraceptives, pp. 199–215 ( Philadelphia: Harper & Row )

    Google Scholar 

  21. Hardt, W., Schmidt-Gollwitzer, K., Nevinny-Stickel, J. and Schmidt-Gollwitzer, M. (1982). Fortschritte in der kontrazeptiven Anwendung des LHRH Agonistes Buserelin: Diskontinuierliche Medikation mit gestageninduzierter Abbruchblutung (Progress in contraceptive application of the LHRH agonist, buserelin: discontinuous medication with progestogen-induced withdrawal bleeding). Gesburtsch. Frauenheilk, 42, 874

    Article  CAS  Google Scholar 

  22. Flowers, C. E., Wilborn, W. H. and Hyde, B. M. (1983). Mechanisms of uterine bleeding in postmenopausal patients receiving estrogen alone or with a progestin. Obstet. Gynecol, 61, 135

    PubMed  Google Scholar 

  23. Casper, R. F., Sheehan, K. L. and Yen, S. S. C. (1980). Chorionic gonadotropin prevents LRF agonist-induced luteolysis in the human. Contraception, 21, 471

    Article  PubMed  CAS  Google Scholar 

  24. Bergquist, C., Nillius, S. J. and Wide, L. (1980). Luteolysis induced by a luteinizing hormone-releasing hormone agonist is prevented by human chorionic gonadotropin. Contraception, 22, 341

    Article  PubMed  CAS  Google Scholar 

  25. Meldrum, D. R., Chang, R. J., Lu, J., Vale, W., Rivier, J. and Judd, H. L. (1982). ‘Medical oophorectomy’ using a longacting GnRH agonist — a possible new approach to the treatment of endometriosis. J. Clin. Endocrinol. Metab, 54, 1081

    Article  Google Scholar 

  26. Strathy, J. H., Molgaard, C. A., Coulam, C. B. and Melton, L. J. (1982). Endometriosis and infertility: a laparascopic study of endometriosis among fertile and infertile women. Fertil. Steril, 38, 667

    PubMed  CAS  Google Scholar 

  27. Tolis, G., Ackermann, D., Stellos, A., et al (1982). Tumor growth inhibition in patients with prostatic carcinoma treated with luteinizing hormone-releasing hormone agonists. Proc. Natl. Acad. Sci. USA, 79, 1658

    Article  PubMed  CAS  Google Scholar 

  28. Borgmann, V., Hardt, W., Schmidt-Gollwitzer, M., Adenauer, H. and Nagel, R. (1982). Sustained suppression of testosterone production by the luteinizing hormone-releasing hormone agonist Buserelin in patients with advanced prostate carcinoma: a new therapeutic approach? Lancet, 1, 1097

    Article  PubMed  CAS  Google Scholar 

  29. Klijn, J. G. M. and DeJong, F. H. (1982). Treatment with a luteinizing hormone-releasing hormone analogue (Buserelin) in pre-menopausal patients with metastatic breast cancer. Lancet, 1, 1213

    Article  PubMed  CAS  Google Scholar 

  30. Cetel, N. S., Rivier, J., Vale, W. and Yen, S. S. C. (1983). The dynamics of gonadotropin inhibition in women induced by an antagonistic analogue of GnRH. J. Clin. Endocrinol. Metab (In press)

    Google Scholar 

Download references

Authors
  1. J. Sandow
    View author publications

    You can also search for this author in PubMed Google Scholar

Editor information

Editors and Affiliations

  1. TCD Unit, Rotunda Hospital Dublin, Dublin, Ireland

    Robert F. Harrison

  2. Department of Obstetrics and Gynaecology, Trinity College Unit, Rotunda Hospital, Dublin 2, Ireland

    John Bonnar

  3. Department of Midwifery and Gynaecology, Queen’s University Belfast, BT9 7AE, Belfast, Northern Ireland

    William Thompson

Rights and permissions

Reprints and permissions

Copyright information

© 1984 MTP Press Limited

About this chapter

Cite this chapter

Sandow, J. (1984). Reproductive releasing hormones — the future. In: Harrison, R.F., Bonnar, J., Thompson, W. (eds) Fertility and Sterility. Springer, Dordrecht. https://doi.org/10.1007/978-94-015-1308-1_4

Download citation

  • DOI: https://doi.org/10.1007/978-94-015-1308-1_4

  • Publisher Name: Springer, Dordrecht

  • Print ISBN: 978-94-015-1310-4

  • Online ISBN: 978-94-015-1308-1

  • eBook Packages: Springer Book Archive

Publish with us

Policies and ethics

Search

Navigation